Generate a tailored SOP for Dr. Michael Kharas. Improve your application with a focused, well-structured draft.
Michael Kharas is an accomplished cancer biologist specializing in RNA regulators and their role in the self-renewal of normal and leukemic hematopoiesis. Leading the Kharas Lab at the Sloan Kettering Institute within the Molecular Pharmacology Program, Dr. Kharas focuses on identifying critical pathways that govern normal leukemic hematopoietic cells. He holds a Ph.D. from the University of California, Irvine, and has been instrumental in enhancing our understanding of cancer cell vulnerabilities for developing targeted therapeutics. His research interests encompass acute myeloid leukemia and the underlying genetic mechanisms that affect the behavior of blood cancer cells. The lab employs innovative techniques to investigate the functions of RNA and associated molecules, aiming for breakthroughs that can lead to improved treatment strategies for leukemia.
The program is hosted by the Weill Cornell Graduate School of Medical Sciences in partnership with the Sloan Kettering Institute. GRE scores are optional.